- Home
- AQST vs TALK Comparison
AQST vs TALK Comparison
Compare AQST & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | TALK |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 442.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AQST | TALK |
|---|---|---|
| Price | $5.79 | $3.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $8.83 | $4.83 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | $43,397,000.00 | ★ $214,593,000.00 |
| Revenue This Year | N/A | $23.86 |
| Revenue Next Year | $52.69 | $22.22 |
| P/E Ratio | ★ N/A | $140.51 |
| Revenue Growth | N/A | ★ 18.37 |
| 52 Week Low | $2.12 | $2.22 |
| 52 Week High | $7.55 | $4.36 |
Technical Indicators
Market Signals| Indicator | AQST | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 60.73 |
| Support Level | $5.61 | $3.43 |
| Resistance Level | $6.44 | $3.67 |
| Average True Range (ATR) | 0.31 | 0.14 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 16.00 | 78.69 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.